chrisvoncsefalvay/vaers-outcomes huggingface dataset:
about 16 hours after shot, 102° fever, chills, headache and severe joint pain ( 8 on 1-10 scale) that lasted three days. It was painful to walk or lift my arms. Most severe pain in my hips. By day three,  headache turned to migraine that lasted the rest of the week with nausea and vomiting from dizziness.
Pt developed left testicular pain 19  days after vaccine. Treated for orchitis and had ultrasound showing testicular hypoechoic area. Persisted and suspicious for tumor with internal blood supply. Pt had testicular exploration and biopsy and noted to be a lymphoid mass. No orchitis or epididymitis. Had T and B cells  activated in biopsy.
Subsequent to receiving varicella virus vaccine live the pt developed a varicella like rash.
Pt c/o dizziness post-vaccination. Pt is Type 1 Diabetic with continuous sensor, BG read 158, which Pt states is a drop from after lunch insulin administration. Provided juice and water. Dizziness improved. Vital signs checked 1500- BP 128/78, HR 73, Temp: 99.8, 100.1, O2- 98%. Advised Urgent Care for evaluation.
Narrative:  Patient with PMHx ESRD/HD +  DM2 residing in long term care since 3/21 following Left BKA for gangrene/osteomyelitis. Tested positive for COVID-19 following complaints of malaise/fatigue. Transferred to acute care 8/5. Received dexamethasone and antibiotic therapy for sepsis and acute hypoxic respiratory failure due to COVID-19 pneumonia and possible secondary bacterial community acquired pneumonia. Many difficulties with fistula during dialysis making dialysis difficult. This resulted in multiple electrolyte abnormalities. Had an episode of SVT during dialysis requiring multiple doses of adenosine and amiodarone (bolus + infusion). After this event had severe hypotension and hypoxia associated with dialysis with very little dialysis able to occur. After discussion with family, decision made to transition to hospice care. Final cause of death acute hypoxic respiratory failure secondary to COVID-19 and end-stage renal disease.
Patient reports itchy eyes, runny nose and itching to upper back approx. 3 hours after receiving  influenza vaccine. There were no evidence of injection site swelling, redness, itching or pain. There were no reports or evidence of hives or respiratory distress. The patient was referred to the Hospital's Center for Employee Health and Wellness Clinic for further follow-up by a Medical Provider. The pt was prescribed a Loratadine 10 mg X1 and Medrol dose pack per NP. The pt reported taking the Medrol dose pack and itching was relieved within 2 days post vaccination.
Site: Pain at Injection Site-Medium, Systemic: Abdominal Pain-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Headache-Medium, Systemic: Joint Pain-Medium, Systemic: Nausea-Medium
Localized red, warm , tender, inflammed 20 cm oval around right posterior upper arm 2 days s/p injection with single dose of "tetanus and pertussis" by Pediatrician. Mild fever of 100.0F
Throat swelled up Tongue swelled up Couldnt breath I took 2 benedryl, and inhaller use 2 puffs 1st day 11/17/2021 For 7 days I took 1 benedryl, and use of inhaler.  At the site of injection on the left arm was very agitated and itchy.
Itching at the injection site 10 minutes after injection. Swollen redden area left deltoid area of arm at site of injection noted 9/20 am. The area XXXXinches in diameter warm to touch. Reported it to clinic manager by patient directly who then reported it to the nurse who injected 24 hours after the injection given. It appears to be unusually local reaction advised to speak with Health care provider.
Within 2 weeks of having my second does I started having tinnitus in my left ear. Extremely loud and no other symptoms along with it. Continuous, high pitched ringing in my left ear. It has continued to this day (2/5/2022). I believed a report was filed but i just found out it was not with my last veers check in.
Always when I got my flu shot I would ache all over; didn't feel well; Initial information received on 02-Dec-2020 regarding an unsolicited valid non-serious case from a patient via social media.  This case involves an adult patient of an unknown gender who reported that always when the patient got flu shot, would ache all over (pain) and did not feel well (malaise), while the patient received INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  No concomitant medication was reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (with an unknown route, frequency, strength, lot number and expiry date) for prophylactic vaccination.  On an unknown date (latency unknown) after starting the suspect vaccine therapy, always when the patient got flu shot, would ache all over (pain). No fever but the patient did not feel well (malaise). The patient guessed not as bad as the flu.  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Fatigue, muscle ache and joint pain. Lasted April 28 and 29, then subsided.
Headache within 30 minutes persisting for 2-3 days. Dizziness, described as "wobbly" feeling 'foggy' thinking, inability to concentrate. Reported shorter duration headache with previous doses.
This spontaneous report as received from a consumer reporting on her 17 year old male son who in July 2011 was vaccinated with a dose of GARDASIL (dose, route and lot number not provided). The patient's mother stated that her son had not received doses 2 or 3 of the GARDASIL series until this time. Additional information is not expected.
shortness of breath; worsened on Sunday; She had a fever Tuesday night; Her HR was 130; She feels tired and weak; She feels tired and weak; This is a spontaneous report from a contactable consumer, the patient via Pfizer. A 2-decade-old (in her late 20's) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration in Jan2021 as single for COVID-19 immunization. Medical history included allergy induced asthma. She had multiple bouts of pneumonia as a child and was also prone to bronchitis. The patient's concomitant medications were not reported. Patient received her 2nd dose of vaccine on Friday. On Saturday, patient noticed some shortness of breath which worsened on Sunday. Patient saw her doctor on Monday. Patient had a D-dimer that was normal. She was started on steroids. She had a fever Tuesday night. She had a negative COVID test and chest X-ray on Wednesday. After lunch, shortness of breath pronounced. Her HR was 130. She felt tired and weak. It was reported that the events took place after the use of product. Outcome of the events shortness of breath and worsened on Sunday was not recovered while of HR was 130, fever, tired and weak was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 01-JAN-2009, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from his use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to himself, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
3 days after 1st shot "I" suddenly became sick to "my" stomach, with chills and a fever; 3 days after 1st shot "I" suddenly became sick to "my" stomach, with chills and a fever; 3 days after 1st shot "I" suddenly became sick to "my" stomach/ Nausea; Muscles felt like lead; every joint hurt; Diarrhea; Bad headache; nausea and throwing up; was overall weak; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 6955) via an unspecified route of administration in the arm left on 06Apr2021 at 09:30(at the age of 60-years-old) as a single dose for COVID-19 immunisation. The medical history included diabetic, antiphospholipid syndrome, stage 4 kidney condition and degenerative disc disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. The patient previously took meloxicam (MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. On 09Apr2021 at 21:00, 3 days after 1st shot the patient  suddenly became sick to stomach, with chills and a fever, nausea and throwing up, muscles felt like lead, every joint hurt, diarrhea, bad headache and this was lasted a couple of days and was overall weak. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sick to stomach, with chills and a fever, nausea and throwing up, muscles felt like lead, every joint hurt, diarrhea and bad headache and overall weak was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Persistent and continuous  fatigue, lethargy, weakness, and "brain fog" 7 days post vaccination.  Fever for days 2 and 3.
Stomach cramps, very slight nausea about 45 minutes after shot. Not quite to the point of bending over double in pain. Took a 2 hour nap starting about 3 hours after. After nap, cramps were lessened to just noticeable. Next morning, everything was normal.
pt recvd vax & devel fever of 105 R & sz (tightened up, eyes rolled back in head approx duration 1 min); had given APAP; taken to ER did all kinds tests including strep cult all neg x/WBC; adm to hosp; elevated temp & runny nose; pt shaking
6 days after the shots on 12/21/17 a rash started developing on her face. The rash spread from her face, to her stomach, then to arms/legs area and progressively got worse and her body was covered. She was sleeping more than normal starting on 12/19/17. Her stool changed color and was silver/gray. On 12/24/17 she got a fever that ranged between approximately 100-102 until 12/27/17. On 12/26/17 we went back to the doctor as we suspected this was a vaccine reaction. We were told it could be a coincidence and if it was a reaction from one of the 2 live virus vaccines that it would be an altered form of the virus. Her rash got better starting in early January but didn't fully go away until 1/8/18. However, since then she gets a rash periodically on different spots of her body. We had a wellness visit 3/16/18 and Dr. looked at the rash on her back and referred us to a dermatologist. Dr. seemed concerned that the rash hasn't fully gone away.
On 12/19/18, patient received a dose of the Shingrix vaccination. Three hours after injection, she broke out in itchy hives. On 12/20/2018, she was treated with Prednisone 40mg x 3 days. The rash did resolve, however reappeared 3 days after being off of the prednisone. On 12/27/2018, patient was given a prednisone taper pack for 13 days. All of her symptoms went away, and then reappeared 3 days later. on 1/14/19, she was seen again due to the rash reappearing. The rash appears as welts and is pruritic. She started taking Zyrtec and occasional benadryl in the evenings. She added pepcid to the mix ans well as a topical triamcinolone cream.  She was seen again on 3/22/19 for the same rash which is on her trunk, arms, and palms. She is prescribed clobetasol 0.0s%Q topical, Prednisone 20mg taper, and is also being referred to dermatology. On 4/11/19, she saw dermatology for the rash. She was prescribed zantac 300mg BID with flare up. She followed up on 4/16 with dermatology having red hive-like patches on her hands, trunk, and hairline that resolve with prednisone. The lesions on the hand look like a bruise and start feeling like a "sticker"sensation, the the palm is red and itchy. The lesions last longer than 24 hours. She is diagnosed with urticaria and dermatology believes her rash may be secondary to the Shingrix vaccine. She has a follow-up appointment in 6 weeks.
pt adm w/GBS possibly assoc w/flu vax 2wk prior to admission;ascending neuromuscular deficits noted 2 days prior to admission-h/a 3 days prior to admission;
Patient presented to the ED and was subsequently hospitalized for Severe sepsis with septic shock within 6 weeks of receiving COVID vaccination.
Recieved flu shot 11/21/07. Within 2 days had flu symptons, and within 3 days had the flu fairly bad! As of 11/26 I'm still quiet sick.
Patient received second dose of Pfizer on 3/30/21. On 3/31/21 patient states arm was itchy , red, and swollen. She is still having arm pain and continues to itch 3 weeks later.
This case was reported by a physician via market research and described the occurrence of convulsion in a 6-month-old male subject who was vaccinated with PEDIARIX (GlaxoSmithKline). Concurrent vaccination included PEDIARIX; GlaxoSmithKline; unknown; unknown given on an unspecified dates for dose 1 and 2. On an unspecified date the subject received 3rd dose of PEDIARIX for primary series ("standard dose", unknown details). Within 48 to 72 hours after vaccination with PEDIARIX, the subject experienced fever and convulsion. At an unknown time after vaccination with PEDIARIX, the subject experienced otitis media. Per the physician, the subject had "fever and then develop[ed] short-term convulsion." This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events were unspecified. Report was received from a physician during market research. The physician reported another case with PEDIARIX. See case A1021881A for details on the other case.
Information has been received from a physician concerning a 22 year old white female with asthma, rhinitis allergic, gastroesophageal reflux disease and depression who on 06-JUN-2008 was vaccinated with a first dose of GARDASIL vaccine (yeast) (lot number 658556/1060U) in the left deltoid (injection route not reported). Concomitant therapy included (ADVAIR), (NASONEX), (ACIPHEX), (ZOLOFT), (LOESTRIN) and (FERRUM). On 06-JUN-2008, also reported as within six hours after the vaccination, the patient experienced nausea. The physician reported that the patient had emesis four to five times per day for the next two to three days. The patient had no fever, no abdominal pain and no diarrhea. It was unknown whether the patient sought any medical attention. On 10-JUN-2008, the patient recovered from nausea and emesis. Additional information is not expected.
Patient reported rash on arm and high level of pain in left arm. Patient started benadryl and topical hydrocortisone but no response. Pain increased, arm swelled and redness increased in area. Verified that arm was also hot to the touch. Referred Patient to md in case of skin infection and to evaluate arm.
Symptoms started 9/17/15 - I started experiencing pain and aching in my left shoulder. I was unable to sleep on that shoulder due to the pain. Since that time, I have experienced pain and decreased mobility/range of motion in left shoulder arm.
Information regarding PREVNAR 13 was received from a healthcare professional regarding a patient who experienced inconsolable and high fever. The patient received a dose on an unspecified date. The patient experienced inconsolable and high fever on 29-Jun-2010. The outcome was unknown. No additional information was available at the time of this report.
Painless but extensive area of erythema and swelling over posterior aspect of right arm (16.5cm by 12cm maximum diameter), over 24 hours after immunizations.
Patient was received a dose of IM Benadryl 50mg/ml at 1110. At 1125 the pt received a dose of Moderna vaccine IM right deltoid and began showing s/sx of distress. BP 99/70 pulse 106. At 1128 BP 61/46 pulse 106. IV fluids attempted but unable to gain IV access. EMS arrived on the scene and the pt V/S were WNL. Pt was discharged to home.
5 minutes after recieving vaccine, client passed out and hit his head on counter. Loss of conciseness for appox 1 minute. Client did recover, alert and oriented. Paramedics were called, but client refused to go to ER. Paramedics and nursing staff strongly encouraged patient to go for further evaluation, but client again refused. The companion that came with client stated she would drive him to the hospital. Nursing staff escorted the client to the car and again encouraged to seek further evaluation at the hospital.
Patient's wife called me about 12:15 PM stating patient's lips were swollen. I advised her to seek emergency help. I spoke to patient on 4/24/16 he was recovering and had been treated by Dr.
A third dose of a vaccine was given to a patient upon request at the drop off window. Technician processed the vaccine under covid/flu/pneumonia as first dose and there were no rejections. The dose was administered to the patient and as we were making his vaccine card, we noticed via vaccine reporting system that he received the first two doses in January/February 2021. We spoke about how there was no clinical evidence supporting the need for a third dose. After approaching the patient about why he needed a third dose, he said "I know, I'm bad. My doctor told me to get a third dose because I have underlying medication conditions."  The patient was satisfied with his decision and left the store without waiting the recommended period of time.
Initial report received from a healthcare professional 18 October 2013. A 77-year-old male patient had received an intramuscular dose of FLUZONE HD vaccine (lot number, dose number and anatomical site of administration were not reported) on 10 October 2013. The patient had unknown illness at the time of vaccination and no known allergies. On 11 October 2013 one day after vaccination, the patient had malaise, diarrhea and muscle aches. Laboratory investigation was and corrective treatments were not reported. At the time of this report, the patients had not recovered from events. Documents held by sender: none. Follow up information received from the healthcare professional on 23 January 2014. The female patient had received an intramuscular dose of 0.5 ml of FLUZONE HD (batch number of vacine was U4764AA and expiry date: 27 May 2014) in the left arm.
1/25/22  91 yr/o male who presents to the Emergency Department complaining of worsening covid symptoms. Patient is vaccinated and boostered. States 4 days ago he develop a cough, body aches, shortness of breath, chest pain.  States he was seen at an ICC and diagnosed with Covid.  States he gave him some medications and told him to come the emergency department if he gets worse.  States he feels though his cough and shortness of breath is getting worse.  He describes the pain in his chest as a sharp pain that is worse with coughing but always has some pressure in his chest.  Denies any nausea, vomiting, diarrhea, abdominal pain.  No known fevers at home.  Denies any history of COPD, asthma, CAD, diabetes. Has a remote smoking history.  States he feels generally weak and unwell. Review of Systems  Constitutional: Positive for fatigue. Negative for chills and fever.  HENT: Negative for congestion, sore throat and rhinorrhea.   Eyes: Negative for visual disturbance.  Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Positive for chest pain. Negative for leg swelling.  Gastrointestinal: Negative for abdominal pain, nausea and vomiting.  Genitourinary: Negative for dysuria and hematuria.  Skin: Negative for color change and rash.  Neurological: Negative for light-headedness and headaches.  Hematological: Negative for adenopathy.  1/25/22-Admission: HISTORY OF PRESENT ILLNESS  91-year-old male was diagnosed with Covid 4 days ago.  He has been ill with respiratory symptoms for 9 days now.  He was treated with bronchodilators and steroids as an outpatient without much relief.  He denies loss of taste or smell.  He denies diarrhea.  He has been vaccinated and boosted for Covid.  Denies chest pain.  Sats were 90% on room air     REVIEW OF SYSTEMS  Eyes-no conjunctivitis, no visual loss ENMT-no oral lesions Cardiovascular-no chest pain Respiratory-no hemoptysis GI-no abdominal pain, no diarrhea GU-no dysuria Musculoskeletal-no bone or muscle aches Skin-no rashes Neurological-no paresthesias, no unilateral weaknesses Psychiatric-no confusion/hallucination/delusion SUMMARY OF HOSPITALIZATION 91-year-old male presents with cough, shortness of breath, and required supplemental oxygen.  He has COVID-19 pneumonia and he was treated with supplemental oxygen, dexamethasone, remdesivir.  He was also given full dose Lovenox as recommended by NIH.  Patient clinically improved.  He would likely still need several oxygen at discharge.  He will be treated with another 10 days of dexamethasone.
Information has been received from a physician concerning a female patient who was vaccinated with GARDASIL and experienced syncope, the patient fainted within 15 minutes of receiving GARDASIL.  Subsequently, the patient recovered from syncope on the same day.  No further information provided at the time of reporting.  The patient sought medical attention with a physician.  Additional information has been requested.
This spontaneous report was received from a registered pharmacist refers to a 76 years old male patient with drug reactions/allergies of niacin and with a prior history of shingles (date of shingles was unspecified, but prior to vaccination with ZOSTAVAX). The patient was vaccinated with a dose of ZOSTAVAX (route, dose and lot# not reported) about 3 years ago, about in 2009. There was no concomitant therapy. Recently (about a week to 10 days ago) on approximately 29-SEP-2012 the patient felt like he was having another case of shingles. There was no treatment given for the AE. There was no lab diagnostics studies performed. At the time of reporting, the outcome of the patient was unknown. The patient sought medical attention by contacting the pharmacist. Additional information has been requested.
11/12/23: patient reported sleeping at home tonight and suddenly awakened with respiratory distress. Cam to the ED and tested positive for COVID.
Parents note that patient was extremely fussy for 3 weeks after receiving immunizations.  There were no concurrent illnesses.  No fever, vomiting, diarrhea, congestion, cough or rash.  No lumps at the injection site.